PubMed

Urocortin: a few inflammatory remarks.

Davidson SM, Yellon DM.

Endocrinology. 2009 Dec;150(12):5205-7. No abstract available. PMID: 19933398 [PubMed - in process]

Reply to Landoni et al.

Venugopal V, Ludman A, Yellon DM, Hausenloy DJ.

Eur J Cardiothorac Surg. 2009 Oct 26. [Epub ahead of print] No abstract available. PMID: 19864152 [PubMed - as supplied by publisher]Related articles

GLP-1 therapy: beyond glucose control.

Hausenloy DJ, Yellon DM.

Circ Heart Fail. 2008 Sep;1(3):147-9. No abstract available. PMID: 19808284 [PubMed - indexed for MEDLINE]

Ischaemic Preconditioning and Postconditioning do not Affect Adenosine A(1) and A (2A) Receptor Sensitivity.

Riksen NP, Wynne A, Yellon DM, Hausenloy DJ.

Cardiovasc Drugs Ther. 2009 Sep 26. [Epub ahead of print] No abstract available. PMID: 19784766 [PubMed - as supplied by publisher]Related articles

Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.

Hausenloy DJ, Yellon DM.

Curr Opin Cardiol. 2009 Sep;24(5):473-82.PMID: 19574922 [PubMed - in process]Related articles

Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial.

Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, Lawrence D, Bognolo J, Yellon DM.

Heart. 2009 Oct;95(19):1567-71. Epub 2009 Jun 8.PMID: 19508973 [PubMed - indexed for MEDLINE]Related articles

Preconditioning the diabetic human myocardium.

Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM.

J Cell Mol Med. 2009 Jun 5. [Epub ahead of print]PMID: 19508386 [PubMed - as supplied by publisher]Related articles

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

Lim SY, Davidson SM, Yellon DM, Smith CC.

Basic Res Cardiol. 2009 Nov;104(6):781-92. Epub 2009 May 22.PMID: 19462153 [PubMed - in process]Related articles

The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) rat.

Dixon RA, Davidson SM, Wynne AM, Yellon DM, Smith CC.

J Cardiovasc Pharmacol. 2009 Apr;53(4):311-7.PMID: 19390347 [PubMed - indexed for MEDLINE]Related articles

'Conditioning' the heart during surgery.

Venugopal V, Ludman A, Yellon DM, Hausenloy DJ.

Eur J Cardiothorac Surg. 2009 Jun;35(6):977-87. Epub 2009 Mar 25. Review.PMID: 19324569 [PubMed - indexed for MEDLINE]Related articles

Statins and cardioprotection--more than just lipid lowering?

Ludman A, Venugopal V, Yellon DM, Hausenloy DJ.

Pharmacol Ther. 2009 Apr;122(1):30-43. Epub 2009 Jan 23. Review.PMID: 19318042 [PubMed - indexed for MEDLINE]Related articles

Urocortin: a protective peptide that targets both the myocardium and vasculature.

Davidson SM, Yellon DM.

Pharmacol Rep. 2009 Jan-Feb;61(1):172-82. Review.PMID: 19307705 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

Paiva M, Riksen NP, Davidson SM, Hausenloy DJ, Monteiro P, Gonçalves L, Providência L, Rongen GA, Smits P, Mocanu MM, Yellon DM.

J Cardiovasc Pharmacol. 2009 May;53(5):373-8.PMID: 19295441 [PubMed - indexed for MEDLINE]Related articles

Premature meta-analysis of remote ischemic preconditioning.

Ludman AJ, Hausenloy DJ, Venugopal V, Yellon DM.

Am J Cardiol. 2009 Mar 15;103(6):893-4. No abstract available. PMID: 19268754 [PubMed - indexed for MEDLINE]Related articles

The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium.

Sivaraman V, Hausenloy DJ, Kolvekar S, Hayward M, Yap J, Lawrence D, Di Salvo C, Yellon DM.

J Mol Cell Cardiol. 2009 May;46(5):758-64. Epub 2009 Feb 25.PMID: 19248786 [PubMed - indexed for MEDLINE]Related articles

The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.

Hausenloy DJ, Ong SB, Yellon DM.

Basic Res Cardiol. 2009 Mar;104(2):189-202. Epub 2009 Feb 26. Review.PMID: 19242644 [PubMed - indexed for MEDLINE]Related articles

Cardioprotective growth factors.

Hausenloy DJ, Yellon DM.

Cardiovasc Res. 2009 Jul 15;83(2):179-94. Epub 2009 Feb 13. Review.PMID: 19218286 [PubMed - indexed for MEDLINE]Related articles

Letter to the editor: "Zinc and cardioprotection: the missing link".

Mocanu MM, Yellon DM.

Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H233-4; author reply H235. No abstract available. PMID: 19116335 [PubMed - indexed for MEDLINE]Related articles

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Postgrad Med J. 2008 Nov;84(997):590-8. Review.PMID: 19103817 [PubMed - indexed for MEDLINE]Related articles

Preconditioning and postconditioning: underlying mechanisms and clinical application.

Hausenloy DJ, Yellon DM.

Atherosclerosis. 2009 Jun;204(2):334-41. Epub 2008 Nov 5. Review.PMID: 19081095 [PubMed - indexed for MEDLINE]Related articles

Myocardial protection: is primary PCI enough?

Hausenloy DJ, Yellon DM.

Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):12-3. Epub 2008 Oct 14. No abstract available. PMID: 18852713 [PubMed - indexed for MEDLINE]Related articles

Mitochondrial PINK1--a novel cardioprotective kinase?

Siddall HK, Warrell CE, Davidson SM, Mocanu MM, Yellon DM.

Cardiovasc Drugs Ther. 2008 Dec;22(6):507-8. Epub 2008 Sep 30. No abstract available. PMID: 18825492 [PubMed - indexed for MEDLINE]Related articles

Time to take myocardial reperfusion injury seriously.

Hausenloy DJ, Yellon DM.

N Engl J Med. 2008 Jul 31;359(5):518-20. No abstract available. PMID: 18669431 [PubMed - indexed for MEDLINE]Related articles

Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency.

Siddall HK, Warrell CE, Yellon DM, Mocanu MM.

Basic Res Cardiol. 2008 Nov;103(6):560-8. Epub 2008 Jul 5.PMID: 18604624 [PubMed - indexed for MEDLINE]Related articles

Clinical translation of cardioprotective strategies : report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection.

Hausenloy DJ, Yellon DM.

Basic Res Cardiol. 2008 Sep;103(5):493-500. No abstract available. PMID: 18600363 [PubMed - indexed for MEDLINE]Related articles

Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse.

Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, Marber MS.

Circ Res. 2008 Aug 1;103(3):307-14. Epub 2008 Jun 26.PMID: 18583716 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. Review.PMID: 18480348 [PubMed - indexed for MEDLINE]Related articles

Remote ischaemic preconditioning: underlying mechanisms and clinical application.

Hausenloy DJ, Yellon DM.

Cardiovasc Res. 2008 Aug 1;79(3):377-86. Epub 2008 May 2. Review.PMID: 18456674 [PubMed - indexed for MEDLINE]Related articlesFree article

Wake up and smell the coffee: yet another no go for cardiac patients? : editorial to "caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat" by Ye et al.

Riksen NP, Hausenloy DJ, Yellon DM.

Cardiovasc Drugs Ther. 2008 Aug;22(4):257-9. Epub 2008 Apr 16. No abstract available. PMID: 18415673 [PubMed - indexed for MEDLINE]Related articlesFree article

The novel adipocytokine visfatin exerts direct cardioprotective effects.

Lim SY, Davidson SM, Paramanathan AJ, Smith CC, Yellon DM, Hausenloy DJ.

J Cell Mol Med. 2008 Aug;12(4):1395-403. Epub 2008 Apr 8.PMID: 18400051 [PubMed - indexed for MEDLINE]Related articles

Erythropoietin: ready for prime-time cardioprotection.

Riksen NP, Hausenloy DJ, Yellon DM.

Trends Pharmacol Sci. 2008 May;29(5):258-67. Epub 2008 Mar 21. Review.PMID: 18359096 [PubMed - indexed for MEDLINE]Related articles

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.

Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM.

Basic Res Cardiol. 2008 May;103(3):274-84. Epub 2007 Dec 13.PMID: 18080084 [PubMed - indexed for MEDLINE]Related articles

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Mocanu MM, Yellon DM, Smith CC.

Cardiovasc Drugs Ther. 2007 Dec;21(6):467-9.PMID: 17965927 [PubMed - indexed for MEDLINE]Related articles

Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation.

Mudalagiri NR, Mocanu MM, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Yellon DM.

Br J Pharmacol. 2008 Jan;153(1):50-6. Epub 2007 Oct 22.PMID: 17952111 [PubMed - indexed for MEDLINE]Related articlesFree article

Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin.

Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB, Yellon DM.

Cardiovasc Drugs Ther. 2007 Dec;21(6):409-14.PMID: 17924178 [PubMed - indexed for MEDLINE]Related articles

Myocardial reperfusion injury.

Yellon DM, Hausenloy DJ.

N Engl J Med. 2007 Sep 13;357(11):1121-35. Review. No abstract available. PMID: 17855673 [PubMed - indexed for MEDLINE]Related articles

Preconditioning and postconditioning: new strategies for cardioprotection.

Hausenloy DJ, Yellon DM.

Diabetes Obes Metab. 2008 Jun;10(6):451-9. Epub 2007 Sep 6. Review.PMID: 17825079 [PubMed - indexed for MEDLINE]Related articles

The power of drug co-administration: smaller doses better outcomes.

Mocanu MM, Shakkottai P, Yellon DM.

Cardiovasc Drugs Ther. 2007 Oct;21(5):319-20. Review. No abstract available. PMID: 17786547 [PubMed - indexed for MEDLINE]Related articles

Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism.

Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ.

Circulation. 2007 Sep 18;116(12):1386-95. Epub 2007 Aug 27.PMID: 17724264 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM.

Lancet. 2007 Aug 18;370(9587):575-9.PMID: 17707752 [PubMed - indexed for MEDLINE]Related articles

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC.

Basic Res Cardiol. 2007 Nov;102(6):518-28. Epub 2007 Aug 13.PMID: 17694254 [PubMed - indexed for MEDLINE]Related articles

Preconditioning and postconditioning: united at reperfusion.

Hausenloy DJ, Yellon DM.

Pharmacol Ther. 2007 Nov;116(2):173-91. Epub 2007 Jun 30. Review.PMID: 17681609 [PubMed - indexed for MEDLINE]Related articles

Necrostatin: a potentially novel cardioprotective agent?

Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM.

Cardiovasc Drugs Ther. 2007 Aug;21(4):227-33. Epub 2007 Jul 31.PMID: 17665295 [PubMed - indexed for MEDLINE]Related articles

Postconditioning protects human atrial muscle through the activation of the RISK pathway.

Sivaraman V, Mudalagiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, Yellon DM.

Basic Res Cardiol. 2007 Sep;102(5):453-9. Epub 2007 Jun 5.PMID: 17546527 [PubMed - indexed for MEDLINE]Related articles

Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

Hausenloy DJ, Yellon DM.

Heart Fail Rev. 2007 Dec;12(3-4):217-34. Review.PMID: 17541822 [PubMed - indexed for MEDLINE]Related articles

Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway.

Bose AK, Mocanu MM, Carr RD, Yellon DM.

Cardiovasc Drugs Ther. 2007 Aug;21(4):253-6.PMID: 17541736 [PubMed - indexed for MEDLINE]Related articles

Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.

Ebrahim Z, Yellon DM, Baxter GF.

Exp Gerontol. 2007 Aug;42(8):807-14. Epub 2007 Apr 24.PMID: 17532161 [PubMed - indexed for MEDLINE]Related articles

Ischemic preconditioning targets the reperfusion phase.

Hausenloy DJ, Wynne AM, Yellon DM.

Basic Res Cardiol. 2007 Sep;102(5):445-52. Epub 2007 May 29.PMID: 17530316 [PubMed - indexed for MEDLINE]Related articles

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Lim SY, Davidson SM, Hausenloy DJ, Yellon DM.

Cardiovasc Res. 2007 Aug 1;75(3):530-5. Epub 2007 May 4.PMID: 17512507 [PubMed - indexed for MEDLINE]Related articlesFree article

The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injury.

Hausenloy DJ, Yellon DM.

Heart. 2007 Jun;93(6):649-51. No abstract available. PMID: 17502643 [PubMed - indexed for MEDLINE]Related articles